Skip directly to local search Skip directly to A to Z list Skip directly to navigation Skip directly to site content Skip directly to page options
CDC Home

Volume 17, Number 6—June 2011

Dispatch

Macrolide Resistance in Mycoplasma pneumoniae, Israel, 2010

Diana Averbuch, Carlos Hidalgo-Grass, Allon E. Moses, Dan Engelhard, and Ran Nir-PazComments to Author 
Author affiliations: Author affiliation: Hadassah–Hebrew University Medical Center, Jerusalem, Israel

Main Article

Figure 1

Time elapsed and chromatogram of wild-type Mycoplasma pneumonia strain M129 (ATCC 29342) compared with results from 5 samples from a 6-year-old boy in Israel. The A2063G mutation is shown to be evolving during treatment and predominates at the end.

Figure 1. Time elapsed and chromatogram of wild-type Mycoplasma pneumonia strain M129 (ATCC 29342) compared with results from 5 samples from a 6-year-old boy in Israel. The A2063G mutation is shown to be evolving during treatment and predominates at the end.

Main Article

1These authors contributed equally to this article.

Top of Page

 

Past Issues

Select a Past Issue:

Art in Science - Selections from Emerging Infectious Diseases
Now available for order



CDC 24/7 – Saving Lives, Protecting People, Saving Money. Learn More About How CDC Works For You…

USA.gov: The U.S. Government's Official Web PortalDepartment of Health and Human Services
Centers for Disease Control and Prevention   1600 Clifton Rd. Atlanta, GA 30333, USA
800-CDC-INFO (800-232-4636) TTY: (888) 232-6348 - Contact CDC–INFO